US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist
  • 3.540
  • -0.110-3.01%
Close Oct 4 16:00 ET
28.76MMarket Cap-800P/E (TTM)

Lumos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lumos Pharma Q2 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
202.60K
488.00K
+285.40K
Beat Est.
-61.56%
-7.40%
+140.87%
EPS
-1.25
-0.93
+0.32
Beat Est.
-14.86%
+14.68%
+25.71%
Analyst Rating
Strong Buy

Oct 5, 2024

Lumos Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.552M--
--2024/Q3-- / 168.830K--
Aug 1, 20242024/Q2488.000K / 202.600K--
May 15, 20242024/Q1165.000K / 378.250K--
Mar 7, 20242023/Q4826.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.552M--
--2024/Q3-- / 168.830K--
Aug 1, 20242024/Q2488.000K / 202.600K--
May 15, 20242024/Q1165.000K / 378.250K--
Mar 7, 20242023/Q4826.000K / 0.000--

Unlock Free Earnings Estimates

Lumos Pharma Earnings Reports

  • Lumos Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 2 08:19 ET

  • Lumos Pharma | 10-Q: Q1 2024 Earnings Report

    May 15 22:40 ET

  • Lumos Pharma | 10-K/A: Annual report (Amendment)

    Apr 22 16:32 ET

  • Lumos Pharma | 10-K: FY2023 Annual Report

    Mar 7 16:51 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 5, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data